Vera Therapeutics Inc (VERA) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $42.35
• Market Cap: $2.96B
• EPS: $-3.99
• 52-Week High: $56.05
• 52-Week Low: $18.53

Market Sentiment

Vera Therapeutics Inc currently has a Neutral sentiment score of 0.13.

About Vera Therapeutics Inc

Vera Therapeutics Inc. is a clinical-stage biotechnology company based in South San Francisco, California, specializing in the development of innovative therapies for serious immune-mediated diseases. Committed to addressing significant unmet medical needs, Vera's pipeline includes promising candidates designed to enhance patient outcomes and quality of life. With a focus on cutting-edge immunology, the company is well-positioned to lead advancements in therapeutic strategies that could trans...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Vera Therapeutics Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does VERA pay dividends?

Vera Therapeutics Inc (VERA) does not currently pay a regular dividend.

What is VERA's market cap?

Vera Therapeutics Inc (VERA) has a market capitalization of $2.96B with a current stock price of $42.35.